Alistair Lindsay talks to Leong Ng about his work into using biomarkers to identify which groups of patients will benefit from ACE inhibition after acute coronary syndrome.
See also:
Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP http://bit.ly/11hAfKc
